Efficacy and safety of dulaglutide in patients with absolute insulin deficiency Cover

.blurhash-client-img { display: none !important; }

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency

Endocrine Regulations

Volume 53 (2019): Issue 3 (July 2019)

By: Eiji Kutoh, Jyunka Hayashi and Alexandra N. Kuto

Open Access

|Aug 2019

Authors

Eiji Kutoh

ekuto-biomed@umin.ac.jp

Department of Clinical Research, Biomedical Center, Tokyo, Japan

Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, Japan

Jyunka Hayashi

Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan

Alexandra N. Kuto

Department of Clinical Research, Biomedical Center, Tokyo, Japan

DOI: https://doi.org/10.2478/enr-2019-0019 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 187 - 190

Published on: Aug 24, 2019

Published by: Slovak Academy of Sciences, Mathematical Institute

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

type 1 diabetes,

insulin deficiency

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2019 Eiji Kutoh, Jyunka Hayashi, Alexandra N. Kuto, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 53 (2019): Issue 3 (July 2019)Next article